The Chinese migrants trying to get into the U...

In the final episode of our series on the weight-loss drug boom, we explore how the global surge in demand for obesity medications could be reshaping the business landscape. From established companies rethinking their business models, to startups seeking to capitalise on shifting ...  Show more

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily se ...  Show more

<div class="DraftEditor-paragraphElement" data-block="true" data-editor="9kbq0" data-offset-key="6fjb5-0-0"> <div class= "public-DraftStyleDefault-block public-DraftStyleDefault-ltr" data-offset-key="6fjb5-0-0"><span data-offset-key= "6fjb5-0-0"><span data-text="true">In this tra ...  Show more

This special weekend episode is all about China. Meet the new migrants making the arduous trek over the Mexico-U.S. border. We talk with those who have left China and find out how they arrived on the Darien Gap. Plus a hot new trend seizes the young and unemployed – Buddhist devo ...  Show more

Ankle monitors and clunky apps make it hard for immigrants awaiting a hearing to start a life in the U.S. Although advocates argue that there are less intrusive methods, whole businesses exist to electronically surveil migrants. That old saying — people versus profit. Then, we’ll ...  Show more

On today’s show we’re talking about the immigration, migration, deportation, and human lives. Earlier this week I had a conversation with Juan. He’s Mexican and lived in Austin Texas from the age of 5 until the age of 27 when he was deported back to Mexico. Juan entered the US ...